Company intelligence / Profile preview

Recreatives Industries

Tarrytown, New York, United States

Ownership: Private
Development stage: Other

Overview

Recreativ is an early-stage biotechnology company focused on the field of regenerative medicine and immunology. Founded by former high-level executives from Regeneron, the company aims to develop therapies that "re-create" healthy human physiological states by restoring tissue function and immune homeostasis. Their approach leverages deep expertise in cytokine biology and tissue engineering to address chronic inflammatory conditions, oncology, and aging-related diseases. Recreativ operates primarily in stealth mode as it advances its proprietary platform toward initial clinical candidates.

Therapeutic areas: OncologyOtherImmunology
Modalities: BiologicCell therapyRecombinant protein
Industry: Biotech

Beyond the preview

Go deeper on Recreatives Industries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recreatives Industries.

Explore the full profile